Nutrition and Ageing

Priority Area Leads: Professor Janet Lord, School of Immunity and Infection, j.m.lord@bham.ac.uk; Professor Janice Thompson, Sport and Exercise Science, janice.thompson@bristol.ac.uk (to start at Birmingham September 2012 but already engaged with Birmingham Fellows process)

Ageing research at Birmingham is truly multidisciplinary, ranging from understanding the basic mechanisms of ageing within key organ systems: notably the musculoskeletal, endocrine and immune systems and how these lead to frailty. This knowledge is then translated into lifestyle and pharmacological interventions to improve human healthspan. We are seeking world class early stage researchers to join our MRC-ARUK Centre of excellence in Musculoskeletal Ageing Research to build capacity in ageing research and especially in the area of nutrition in ageing.

Current research

Research into human ageing is an area of excellence and multidisciplinary research capacity at Birmingham, as evidenced by the recent award of The MRC-ARUK Centre for Musculoskeletal Ageing Research, led by Professor Janet Lord.  The Centre is a partnership between the University of Birmingham and University of Nottingham with a broad remit stretching from basic mechanisms underlying the age-related loss of muscle to interventions to minimise this process. We are in particular seeking world class early career researchers with an interest in the role played by nutrition in the ageing process:

  •  How under and over nutrition impact upon physical functioning
  •  How ageing compromises anabolic responses leading to tissue atrophy (e.g. sarcopaenia)
  •  Nutritional interventions to reduce the impact of ageing
  • Fellows would be members of, and contribute to the activity of, the MRC-ARUK Centre for Musculoskeletal Ageing Research. The themes within the Centre are:
  •  Musculoskeletal Ageing mechanisms
  •  Neuromuscular Ageing
  •  Interventions for Musculoskeletal Health
  •  Systems Biology of Ageing
  •  Motivation for Lifestyle Change

Nutrition features within all themes but especially in the Musculoskeletal Ageing and Interventions themes. For example, Centre researchers Professor Anton Wagenmakers and Professor Paul Greenhaff (Nottingham University) have established that older adults are less efficient in maintaining muscle tissue in part because muscle protein synthesis is compromised, termed “anabolic blunting”. Current research includes determining effects of varying the frequency and quantities of feeding to overcome anabolic blunting, and developing feeding strategies to implement this at population level.

Subcutaneous and visceral adipose tissue increases with age leading to hypertriglyceridemia and elevated inflammatory cytokines and adipokines, which contribute to skeletal muscle insulin resistance.  Other ongoing research is testing the hypothesis that the size of the fatty acid flux and release of inflammatory cytokines from adipose tissue stores modulate the degree of blunting of anabolic signals. The mechanisms involved are also being investigated. Elevated muscle cytokines (TNFα, IL6) in obese elderly disturb Akt signaling and activate FOXO transcription factors targeting muscle ubiquitin ligases and pyruvate dehydrogenase kinase isoforms, which collectively suppress muscle protein synthesis, increase degradation and carbohydrate oxidation. Centre researchers are testing the hypothesis that age-related hypertriglyceridemia and systemic inflammation drive molecular and cellular mechanisms that accelerate musculoskeletal ageing. In addition Professor Ed Rainger is focussing on how omega 3 fatty acids, which are high in fish oil supplements, influence inflammation in various tissues by effects on immune cell migration and function.

The metabolic benefits of weight loss are well established and there is considerable interest at UoB in the detrimental effects of obesity, including on the musculoskeletal system. This includes research in the Centre for Obesity Research led by Dr Jeremy Tomlinson to determine the impact of structured, supervised weight loss on musculoskeletal mass, function and the molecular adaptation in muscle in overweight elderly subjects. Additional studies are exploring novel uses for L-leucine and its metabolite (HMB; stimulators of mTOR), with the aim of improving anabolic responses to feeding in elderly skeletal muscle.

The role of age-related endocrine changes are also a major research topic within the Centre, as such hormone changes impact upon the anabolic potential of muscle and one in old age. Professor Paul Stewart and Dr Mark Cooper have shown that 11β-HSD1 expression and activity within muscle and bone increases with age, through an inflammatory cytokine driven (NF-kB mediated) pathway, and the consequent cortisol excess contributes to ‘unhealthy’ musculoskeletal ageing and a reduced ability to maintain muscle and bone. In collaboration with pharmaceutical partners, the effect of short-term administration of 11β-HSD1 inhibitors on bone turnover and skeletal muscle function is being assessed. An additional major endocrine change investigated by Professor Lord and Professor Wiebke Arlt is adrenopause, in which production of the androgen DHEA declines from the age of 30 with profound effect on physical and cognitive function as well as immunity. Importantly, DHEA supplementation has benefits for muscle function, as an androgen precursor raising its endogenous production will provide an androgen agonistic signal to improve muscle mass. Ongoing studies are using DHEA supplementation to prevent frailty in older adults after hip fracture.

Finally the recent appointment of Professor Janice Thompson brings expertise in nutritional assessments and interventions in ethnic minority groupings. The ability to assess dietary intake in a culturally sensitive way in different community settings, will broaden the ability of UoB researchers to carry out lifestyle assessments and interventions in our significant ethnic minority populations. Dr Gareth Wallis is another recent appointment with expertise in nutritional supplementation to improve performance in athletes, but who is now using his knowledge to benefit older adults.

Research facilities and potential for collaboration

Ageing research is present in all colleges at UoB and is very much a multidisciplinary and collaborative topic facilitated through the Centre for Healthy Ageing Research. The two colleges with the greatest involvement are however Medical and Dental Sciences and Life and Environmental Sciences, both key players in the MRC-ARUK Centre. The hub of the Centre is located in purpose built laboratories occupying over 2000m2 in the new Queen Elizabeth super hospital, which is adjacent to the medical school. This space has its own clinical research facility for clinical intervention studies, operating as a spoke of the main Wellcome Trust CRF and complementing the CRF in the School of Sport and Exercise Sciences (SSES) which has facilities for exercise interventions studies.

Further state of the art facilities such as second generation sequencing, extensive imaging facilities, cell sorting, are located in the technology hub within the Institute for Biomedical Research (IBR). A third unique facility is the human metabolism isotope tracer technology located in SSES, to be run as a national platform for human metabolism studies in collaboration with Professor Paul Greenhaff at the University of Nottingham.

Finally, human ageing studies cannot be done without access to healthy older humans. This is achieved at UoB via the Birmingham 1000 Elders group, a large cohort of healthy older adults aged over 65 who volunteer to take part in research at the University. For researchers interested in different disease cohorts this is expedited by the close collaboration of clinicians with basic scientists at UoB, and notably by the location of the MRC-ARUK Centre hub within the QE hospital. Industrial collaboration is also important in the area of ageing research and development of interventions and there are strong links with a range of industrial partners including GSK, Novartis, Astra Zeneca, Smith and Nephew and Unilever.